| 000 | 01753 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517150406.0 | ||
| 264 | 0 | _c20171031 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1460-2083 | ||
| 024 | 7 |
_a10.1093/hmg/ddx138 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaniunaite, Kristina | |
| 245 | 0 | 0 |
_aClinical significance of miRNA host gene promoter methylation in prostate cancer. _h[electronic resource] |
| 260 |
_bHuman molecular genetics _c07 2017 |
||
| 300 |
_a2451-2461 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 | _aDatabases, Nucleic Acid |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aGene Expression Profiling _xmethods |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMethylation |
| 650 | 0 | 4 |
_aMicroRNAs _xchemistry |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aProstate _xmetabolism |
| 650 | 0 | 4 | _aProstatectomy |
| 650 | 0 | 4 |
_aProstatic Hyperplasia _xgenetics |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xgenetics |
| 700 | 1 | _aDubikaityte, Monika | |
| 700 | 1 | _aGibas, Povilas | |
| 700 | 1 | _aBakavicius, Arnas | |
| 700 | 1 | _aRimantas Lazutka, Juozas | |
| 700 | 1 | _aUlys, Albertas | |
| 700 | 1 | _aJankevicius, Feliksas | |
| 700 | 1 | _aJarmalaite, Sonata | |
| 773 | 0 |
_tHuman molecular genetics _gvol. 26 _gno. 13 _gp. 2451-2461 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/hmg/ddx138 _zAvailable from publisher's website |
| 999 |
_c27070283 _d27070283 |
||